Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) EBIT Margin (2020 - 2026)

Sight Sciences has reported EBIT Margin over the past 6 years, most recently at 18.0% for Q4 2025.

  • For Q4 2025, EBIT Margin rose 4454.0% year-over-year to 18.0%; the TTM value through Dec 2025 reached 47.96%, up 1532.0%, while the annual FY2025 figure was 47.95%, 1532.0% up from the prior year.
  • EBIT Margin for Q4 2025 was 18.0% at Sight Sciences, up from 39.71% in the prior quarter.
  • Over five years, EBIT Margin peaked at 18.0% in Q4 2025 and troughed at 149.14% in Q1 2022.
  • A 5-year average of 82.36% and a median of 77.79% in 2024 define the central range for EBIT Margin.
  • Biggest five-year swings in EBIT Margin: skyrocketed 13123bps in 2021 and later crashed -4435bps in 2022.
  • Year by year, EBIT Margin stood at 100.21% in 2021, then rose by 17bps to 83.01% in 2022, then increased by 29bps to 59.25% in 2023, then decreased by -6bps to 62.54% in 2024, then surged by 71bps to 18.0% in 2025.
  • Business Quant data shows EBIT Margin for SGHT at 18.0% in Q4 2025, 39.71% in Q3 2025, and 59.64% in Q2 2025.